177 related articles for article (PubMed ID: 34159760)
1. Water-Soluble Gold(III)-Metformin Complex Alters Mitochondrial Bioenergetics in Breast Cancer Cells.
Hyun Kim J; Ofori S; Mertens RT; Parkin S; Awuah SG
ChemMedChem; 2021 Oct; 16(20):3222-3230. PubMed ID: 34159760
[TBL] [Abstract][Full Text] [Related]
2. Sulfonamide metformin derivatives induce mitochondrial-associated apoptosis and cell cycle arrest in breast cancer cells.
Markowicz-Piasecka M; Huttunen J; Zajda A; Sikora J; Huttunen KM
Chem Biol Interact; 2022 Jan; 352():109795. PubMed ID: 34953865
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes.
De Nisi A; Bergamini C; Leonzio M; Sartor G; Fato R; Naldi M; Monari M; Calonghi N; Bandini M
Dalton Trans; 2016 Jan; 45(4):1546-53. PubMed ID: 26687209
[TBL] [Abstract][Full Text] [Related]
4. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
[TBL] [Abstract][Full Text] [Related]
5. Gold amides as anticancer drugs: synthesis and activity studies.
Newcombe S; Bobin M; Shrikhande A; Gallop C; Pace Y; Yong H; Gates R; Chaudhuri S; Roe M; Hoffmann E; Viseux EM
Org Biomol Chem; 2013 May; 11(19):3255-60. PubMed ID: 23584015
[TBL] [Abstract][Full Text] [Related]
6. A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.
Rackham O; Nichols SJ; Leedman PJ; Berners-Price SJ; Filipovska A
Biochem Pharmacol; 2007 Oct; 74(7):992-1002. PubMed ID: 17697672
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer.
Gambini V; Tilio M; Maina EW; Andreani C; Bartolacci C; Wang J; Iezzi M; Ferraro S; Ramadori AT; Simon OC; Pucciarelli S; Wu G; Dou QP; Marchini C; Galassi R; Amici A
Eur J Med Chem; 2018 Jul; 155():418-427. PubMed ID: 29906688
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
[TBL] [Abstract][Full Text] [Related]
9. Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs.
García-Moreno E; Gascón S; Atrián-Blasco E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
Eur J Med Chem; 2014 May; 79():164-72. PubMed ID: 24732792
[TBL] [Abstract][Full Text] [Related]
10. The fluxional amine gold(III) complex as an excellent catalyst and precursor of biologically active acyclic carbenes.
Montanel-Pérez S; Herrera RP; Laguna A; Villacampa MD; Gimeno MC
Dalton Trans; 2015 May; 44(19):9052-62. PubMed ID: 25893402
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
[TBL] [Abstract][Full Text] [Related]
12. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles.
Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L
Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157
[TBL] [Abstract][Full Text] [Related]
13. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
[TBL] [Abstract][Full Text] [Related]
14. New Derivatives of Bacteriopurpurin with Thiolated Au (I) Complexes: Dual Darkand Light Activated Antitumor Potency.
Grin MA; Tikhonov SI; Petrova AS; Pogorilyy VA; Noev АN; Tatarskiy VV; Shpakovsky DB; Milaeva ER; Kalinina EV; Chernov NN; Shtil АА; Mironov AF; Kaprin AD; Filonenko EV
Anticancer Agents Med Chem; 2020; 20(1):49-58. PubMed ID: 31368879
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of gold(III) complexes on A549 human lung carcinoma epithelial cell line.
Arsenijević M; Milovanovic M; Volarevic V; Djeković A; Kanjevac T; Arsenijević N; Dukić S; Bugarcić ZD
Med Chem; 2012 Jan; 8(1):2-8. PubMed ID: 22420544
[TBL] [Abstract][Full Text] [Related]
16. Acridine-decorated cyclometallated gold(iii) complexes: synthesis and anti-tumour investigations.
Williams MRM; Bertrand B; Fernandez-Cestau J; Waller ZAE; O'Connell MA; Searcey M; Bochmann M
Dalton Trans; 2018 Oct; 47(38):13523-13534. PubMed ID: 30204186
[TBL] [Abstract][Full Text] [Related]
17. A Multitarget Gold(I) Complex Induces Cytotoxicity Related to Aneuploidy in HCT-116 Colorectal Carcinoma Cells.
Zhang JJ; Abu El Maaty MA; Hoffmeister H; Schmidt C; Muenzner JK; Schobert R; Wölfl S; Ott I
Angew Chem Int Ed Engl; 2020 Sep; 59(38):16795-16800. PubMed ID: 32529715
[TBL] [Abstract][Full Text] [Related]
18. Serum-Stable Gold(III) Bisphosphine Complex Induces Mild Mitochondrial Uncoupling and In Vivo Antitumor Potency in Triple Negative Breast Cancer.
Arojojoye AS; Olelewe C; Gukathasan S; Kim JH; Vekaria H; Parkin S; Sullivan PG; Awuah SG
J Med Chem; 2023 Jun; 66(12):7868-7879. PubMed ID: 37279147
[TBL] [Abstract][Full Text] [Related]
19. Sulfenamide derivatives can improve transporter-mediated cellular uptake of metformin and induce cytotoxicity in human breast adenocarcinoma cell lines.
Markowicz-Piasecka M; Huttunen J; Sikora J; Huttunen KM
Bioorg Chem; 2019 Jun; 87():321-334. PubMed ID: 30913467
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity exerted by tricyclohexylphosphanegold(I) n-mercaptobenzoate against MCF-7 and A2780 cell lines: the role of p53 signaling pathways.
Ang KP; Chan PF; Hamid RA
Biometals; 2021 Feb; 34(1):141-160. PubMed ID: 33196940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
